+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Insulin Market by Product, by Application, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

  • ID: 4749615
  • Report
  • Region: Global
  • 291 Pages
  • Prescient & Strategic Intelligence Private Limited
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton
  • Biocon Limited
  • Dickinson and Company
  • Eli Lilly and Company
  • Medtronic plc
  • MORE
The human insulin (HI) market size is predicted to reach $70.6 billion by 2023, increasing population exposure to key risk factors leading to diabetes, technological advancements in insulin delivery devices, growth in the number of diabetic patients, and growing geriatric population are the factors driving the market growth.

The products available in the human insulin market are HI drugs and delivery devices. Among these products, HI delivery devices is expected be the faster growing category, globally, advancing at a CAGR of 11.1% during the forecast period. This is attributed to increasing prevalence of diabetes, and growing focus of insulin pen manufacturers on countries with large number of diabetic patients, such as China and India. Furthermore, technological advancements in pens and medical reimbursements offered in developed regions are some of the other factors driving the growth of this product category.

HI drugs are further classified into analogs and biologics. There are various brands available for HI analogs and biologics in the global human insulin market. The HI analogs are also classified on the basis of type into rapid-acting, long-acting, and premixed insulin. Similarly, HI biologics are bifurcated into intermediate/rapid-acting, short-acting, premixed, on the basis of type. Among these, short-acting insulin is predicted to be the fastest growing category in the global market, demonstrating a CAGR of 5.8%.

On the basis of application, the human insulin market is categorized into type II diabetes, type I diabetes, and gestational diabetes and prediabetes. Type II diabetes is expected to be the fastest growing application area in this market, advancing at a CAGR of 9.1% during the forecast period, which is attributed to increasing prevalence of type II diabetes, globally.

The human insulin market in APAC is expected to witness fastest growth, due to rising prevalence of diabetes, unhealthy lifestyle choices due to rapid urbanization, and growing aging population in the countries like China and India. Additionally, major players as a part of their business strategy are investing in the untapped market of the region leading to its fastest growth.

The International Diabetes Federation (IDF) reported in 2015, that an estimated 82 million people aged between 20 to 79 years suffered from diabetes in South-East Asia in 2017. Furthermore, in response to the growing diabetes and lifestyle diseases, the government of the developing countries, such as China, and India, are preparing action plans in order to expand diabetes screening at the primary health-care level, train health-care workers, and take preventative measures. Thus, such initiatives plans are expected to support the growth of human insulin market in APAC.

Furthermore, the World Health Organization (WHO) developed the action plan for the prevention and control of non-communicable diseases (NCDs) in South-East Asia 2013-2020. This plan provided a roadmap for the implementation of policies and programmes at regional and national level, thus fueling the human insulin market growth in the region.

In order to increase their market share, key players of the human insulin industry are pursuing partnerships and collaborations. For instance, in October 2018, Ypsomed AG collaborated with Koninklijke Philips N.V. (Philips) to jointly develop and deploy new digital self-medication adherence monitoring services based on Ypsomed’s connected devices and Philips’ cloud based HealthSuite digital platform.

In August 2018, Ypsomed AG entered into partnership with JRDF, the leading global organization funding type I diabetes research, as a part of JDRF’s Open-Protocol Automated Insulin Delivery (AID) Systems Initiative. Under the terms of this partnership, JRDF will contribute financial resources to help Ypsomed AG to accelerate development of the next generation, fully interoperable myLife YpsoPump insulin pump.

Some of the other key players operating in the human insulin industry are B. Braun Melsungen AG; Becton, Dickinson and Company; Eli Lilly and Company; Novo Nordisk A/S; Sanofi; Wockhardt Limited; Biocon Limited; Medtronic plc; and Gulf Pharmaceutical Industries (Julphar).
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton
  • Biocon Limited
  • Dickinson and Company
  • Eli Lilly and Company
  • Medtronic plc
  • MORE

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by Geography
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Human insulin (HI) drugs
4.1.1.1.1 HI analogs
4.1.1.1.1.1 By type
4.1.1.1.1.1.1 Long-acting
4.1.1.1.1.1.2 Rapid- acting
4.1.1.1.1.1.3 Premixed
4.1.1.1.1.2 By brand
4.1.1.1.1.2.1 Lantus
4.1.1.1.1.2.2 Apidra
4.1.1.1.1.2.3 Levemir
4.1.1.1.1.2.4 NovoRapid/ NovoLog
4.1.1.1.1.2.5 Novomix
4.1.1.1.1.2.6 Humalog
4.1.1.1.1.2.7 Others
4.1.1.1.2 HI biologics
4.1.1.1.2.1 By type
4.1.1.1.2.1.1 Short-acting
4.1.1.1.2.1.2 Intermediate/rapid-acting
4.1.1.1.2.1.3 Premixed
4.1.1.1.2.2 By brand
4.1.1.1.2.2.1 Humulin
4.1.1.1.2.2.2 Insuman
4.1.1.1.2.2.3 Others
4.1.1.2 HI delivery devices
4.1.1.2.1 Syringes
4.1.1.2.2 Pens
4.1.1.2.2.1 Disposable
4.1.1.2.2.2 Reusable
4.1.1.2.3 Pen needles
4.1.1.2.4 Pumps
4.1.1.2.5 Others
4.1.2 By Application
4.1.2.1 Type 1 diabetes
4.1.2.2 Type 2 diabetes
4.1.2.3 Gestational diabetes and prediabetes
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Surge in the usage of insulin delivery devices for administering human insulin
4.2.1.2 Growing significance of home infusion therapy for diabetes treatment
4.2.2 Drivers
4.2.2.1 Growth in the number of diabetic patients
4.2.2.2 Growing geriatric population
4.2.2.3 Increasing population exposure toward key risk factors leading to diabetes
4.2.2.4 Technological advancements in insulin delivery devices
4.2.3 Impact analysis of drivers on market forecast
4.2.4 Opportunities
4.2.4.1 Favorable health insurance and reimbursement scenario
4.2.4.2 Increasing awareness about diabetes care
4.2.4.3 Increasing prevalence of diabetes among children and adolescents
4.2.5 Restraints
4.2.5.1 High cost of human insulin
4.2.5.2 Strict regulatory environment
4.2.5.3 Impact analysis of restraints on market forecast
4.3 Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 HI Drugs Market, by Type
5.1.1.1 HI analogs market, by type
5.1.1.2 HI analogs market, by brand
5.1.1.3 HI biologics market, by type
5.1.1.4 HI biologics market, by brand
5.1.2 HI Delivery Devices Market, by Type
5.1.2.1 HI pens market, by type
5.2 By Application
5.3 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 HI Drugs Market, by Type
6.1.1.1 HI analogs market, by type
6.1.1.2 HI analogs market, by brand
6.1.1.3 HI biologics market, by type
6.1.1.4 HI biologics market, by brand
6.1.2 HI Delivery Devices Market, by Type
6.1.2.1 HI pens market, by type
6.2 By Application
6.3 By Country
6.3.1 U.S. HI Market
6.3.1.1 By product
6.3.1.1.1 HI drugs market, by type
6.3.1.1.1.1 HI analogs market, by type
6.3.1.1.1.2 HI biologics market, by type
6.3.1.1.2 HI delivery devices market, by type
6.3.1.1.2.1 HI pens market, by type
6.3.1.2 By application
6.3.2 Canada HI Market
6.3.2.1 By product
6.3.2.1.1 HI drugs market, by type
6.3.2.1.1.1 HI analogs market, by type
6.3.2.1.1.2 HI biologics market, by type
6.3.2.1.2 HI delivery devices market, by type
6.3.2.1.2.1 HI pens market, by type
6.3.2.2 By application

Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 HI Drugs Market, by Type
7.1.1.1 HI analogs market, by type
7.1.1.2 HI analogs market, by brand
7.1.1.3 HI biologics market, by type
7.1.1.4 HI biologics market, by brand
7.1.2 HI Delivery Devices Market, by Type
7.1.2.1 HI pens market, by type
7.2 By Application
7.3 By Country
7.3.1 Germany HI Market
7.3.1.1 By product
7.3.1.1.1 HI drugs market, by type
7.3.1.1.1.1 HI analogs market, by type
7.3.1.1.1.2 HI biologics market, by type
7.3.1.1.2 HI delivery devices market, by type
7.3.1.1.2.1 HI pens market, by type
7.3.1.2 By application
7.3.2 France HI Market
7.3.2.1 By product
7.3.2.1.1 HI drugs market, by type
7.3.2.1.1.1 HI analogs market, by type
7.3.2.1.1.2 HI biologics market, by type
7.3.2.1.2 HI delivery devices market, by type
7.3.2.1.2.1 HI pens market, by type
7.3.2.2 By application
7.3.3 U.K. HI Market
7.3.3.1 By product
7.3.3.1.1 HI drugs market, by type
7.3.3.1.1.1 HI analogs market, by type
7.3.3.1.1.2 HI biologics market, by type
7.3.3.1.2 HI delivery devices market, by type
7.3.3.1.2.1 HI pens market, by type
7.3.3.2 By application
7.3.4 Italy HI Market
7.3.4.1 By product
7.3.4.1.1 HI drugs market, by type
7.3.4.1.1.1 HI analogs market, by type
7.3.4.1.1.2 HI biologics market, by type
7.3.4.1.2 HI delivery devices market, by type
7.3.4.1.2.1 HI pens market, by type
7.3.4.2 By application
7.3.5 Spain HI Market
7.3.5.1 By product
7.3.5.1.1 HI drugs market, by type
7.3.5.1.1.1 HI analogs market, by type
7.3.5.1.1.2 HI biologics market, by type
7.3.5.1.2 HI delivery devices market, by type
7.3.5.1.2.1 HI pens market, by type
7.3.5.2 By application

Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 HI Drugs Market, by Type
8.1.1.1 HI analogs market, by type
8.1.1.2 HI analogs market, by brand
8.1.1.3 HI biologics market, by type
8.1.1.4 HI biologics market, by brand
8.1.2 HI Delivery Devices Market, by Type
8.1.2.1 HI pens market, by type
8.2 By Application
8.3 By Country
8.3.1 Japan HI Market
8.3.1.1 By product
8.3.1.1.1 HI drugs market, by type
8.3.1.1.1.1 HI analogs market, by type
8.3.1.1.1.2 HI biologics market, by type
8.3.1.1.2 HI delivery devices market, by type
8.3.1.1.2.1 HI pens market, by type
8.3.1.2 By application
8.3.2 China HI Market
8.3.2.1 By product
8.3.2.1.1 HI drugs market, by type
8.3.2.1.1.1 HI analogs market, by type
8.3.2.1.1.2 HI biologics market, by type
8.3.2.1.2 HI delivery devices market, by type
8.3.2.1.2.1 HI pens market, by type
8.3.2.2 By application
8.3.3 India HI Market
8.3.3.1 By product
8.3.3.1.1 HI drugs market, by type
8.3.3.1.1.1 HI analogs market, by type
8.3.3.1.1.2 HI biologics market, by type
8.3.3.1.2 HI delivery devices market, by type
8.3.3.1.2.1 HI pens market, by type
8.3.3.2 By application
8.3.4 Australia HI Market
8.3.4.1 By product
8.3.4.1.1 HI drugs market, by type
8.3.4.1.1.1 HI analogs market, by type
8.3.4.1.1.2 HI biologics market, by type
8.3.4.1.2 HI delivery devices market, by type
8.3.4.1.2.1 HI pens market, by type
8.3.4.2 By application

Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 HI Drugs Market, by Type
9.1.1.1 HI analogs market, by type
9.1.1.2 HI analogs market, by brand
9.1.1.3 HI biologics market, by type
9.1.1.4 HI biologics market, by brand
9.1.2 HI Delivery Devices Market, by Type
9.1.2.1 HI pens market, by type
9.2 By Application
9.3 By Country
9.3.1 Brazil HI Market
9.3.1.1 By product
9.3.1.1.1 HI drugs market, by type
9.3.1.1.1.1 HI analogs market, by type
9.3.1.1.1.2 HI biologics market, by type
9.3.1.1.2 HI delivery devices market, by type
9.3.1.1.2.1 HI pens market, by type
9.3.1.2 By application
9.3.2 Mexico HI Market
9.3.2.1 By product
9.3.2.1.1 HI drugs market, by type
9.3.2.1.1.1 HI analogs market, by type
9.3.2.1.1.2 HI biologics market, by type
9.3.2.1.2 HI delivery devices market, by type
9.3.2.1.2.1 HI pens market, by type
9.3.2.2 By application

Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 HI Drugs Market, by Type
10.1.1.1 HI analogs market, by type
10.1.1.2 HI analogs market, by brand
10.1.1.3 HI biologics market, by type
10.1.1.4 HI biologics market, by brand
10.1.2 HI Delivery Devices Market, by Type
10.1.2.1 HI pens market, by type
10.2 By Application
10.3 By Country
10.3.1 Saudi Arabia HI Market
10.3.1.1 By product
10.3.1.1.1 HI drugs market, by type
10.3.1.1.1.1 HI analogs market, by type
10.3.1.1.1.2 HI biologics market, by type
10.3.1.1.2 HI delivery devices market, by type
10.3.1.1.2.1 HI pens market, by type
10.3.1.2 By application
10.3.2 South Africa HI Market
10.3.2.1 By product
10.3.2.1.1 HI drugs market, by type
10.3.2.1.1.1 HI analogs market, by type
10.3.2.1.1.2 HI biologics market, by type
10.3.2.1.2 HI delivery devices market, by type
10.3.2.1.2.1 HI pens market, by type
10.3.2.2 By application

Chapter 11. Competitive Landscape
11.1 Market Share Analysis of Key Players
11.2 Competitive Analysis of Key Players
11.3 Global Strategic Developments of Key Players
11.3.1 Product Launches/Approvals
11.3.2 Partnerships and Collaborations
11.3.3 Geographic Expansions
11.3.4 Mergers and Acquisitions

Chapter 12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Becton, Dickinson and Company
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Eli Lilly and Company
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Novo Nordisk A/S
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Sanofi
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 Wockhardt Limited
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Ypsomed Holding AG
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 Biocon Limited
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 Medtronic plc
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 Gulf Pharmaceutical Industries (Julphar)
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary

Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

List of Tables
Table 1 Analysis Period Of The Study
Table 2 Impact Analysis Of Drivers On Marekt Forcast
Table 3 Impact Analysis Of Restraints On Marekt Forcast
Table 4 Global Hi Market, By Product, $M (2013-2017)
Table 5 Global Hi Market, By Product, $M (2018-2023)
Table 6 Global Hi Drugs Market, By Type, $M (2013-2017)
Table 7 Global Hi Drugs Market, By Type, $M (2018-2023)
Table 8 Global Hi Analogs Market, By Type, $M (2013-2017)
Table 9 Global Hi Analogs Market, By Type, $M (2018-2023)
Table 10 Global Hi Analogs Market, By Brand, $M (2013-2017)
Table 11 Global Hi Analogs Market, By Brand, $M (2018-2023)
Table 12 Global Hi Biologics Market, By Type, $M (2013-2017)
Table 13 Global Hi Biologics Market, By Type, $M (2018-2023)
Table 14 Global Hi Biologics Market, By Brand, $M (2013-2017)
Table 15 Global Hi Biologics Market, By Brand, $M (2018-2023)
Table 16 Global Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 17 Global Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 18 Global Hi Pens Market, By Type, $M (2013-2017)
Table 19 Global Hi Pens Market, By Type, $M (2018-2023)
Table 20 Global Hi Market, By Application, $M (2013-2017)
Table 21 Global Hi Market, By Application, $M (2018-2023)
Table 22 Global Hi Market, By Region, $M (2013-2017)
Table 23 Global Hi Market, By Region, $M (2018-2023)
Table 24 North America Hi Market, By Product, $M (2013-2017)
Table 25 North America Hi Market, By Product, $M (2018-2023)
Table 26 North America Hi Drugs Market, By Type, $M (2013-2017)
Table 27 North America Hi Drugs Market, By Type, $M (2018-2023)
Table 28 North America Hi Analogs Market, By Type, $M (2013-2017)
Table 29 North America Hi Analogs Market, By Type, $M (2018-2023)
Table 30 North America Hi Analogs Market, By Brand, $M (2013-2017)
Table 31 North America Hi Analogs Market, By Brand, $M (2018-2023)
Table 32 North America Hi Biologics Market, By Type, $M (2013-2017)
Table 33 North America Hi Biologics Market, By Type, $M (2018-2023)
Table 34 North America Hi Biologics Market, By Brand, $M (2013-2017)
Table 35 North America Hi Biologics Market, By Brand, $M (2018-2023)
Table 36 North America Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 37 North America Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 38 North America Hi Pens Market, By Type, $M (2013-2017)
Table 39 North America Hi Pens Market, By Type, $M (2018-2023)
Table 40 North America Hi Market, By Application, $M (2013-2017)
Table 41 North America Hi Market, By Application, $M (2018-2023)
Table 42 North America Hi Market, By Country, $M (2013-2017)
Table 43 North America Hi Market, By Country, $M (2018-2023)
Table 44 U.S. Hi Market, By Product, $M (2013-2017)
Table 45 U.S. Hi Market, By Product, $M (2018-2023)
Table 46 U.S. Hi Drugs Market, By Type, $M (2013-2017)
Table 47 U.S. Hi Drugs Market, By Type, $M (2018-2023)
Table 48 U.S. Hi Analogs Market, By Type, $M (2013-2017)
Table 49 U.S. Hi Analogs Market, By Type, $M (2018-2023)
Table 50 U.S. Hi Biologics Market, By Type, $M (2013-2017)
Table 51 U.S. Hi Biologics Market, By Type, $M (2018-2023)
Table 52 U.S. Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 53 U.S. Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 54 U.S. Hi Pens Market, By Type, $M (2013-2017)
Table 55 U.S. Hi Pens Market, By Type, $M (2018-2023)
Table 56 U.S. Hi Market, By Application, $M (2013-2017)
Table 57 U.S. Hi Market, By Application, $M (2018-2023)
Table 58 Canada Hi Market, By Product, $M (2013-2017)
Table 59 Canada Hi Market, By Product, $M (2018-2023)
Table 60 Canada Hi Drugs Market, By Type, $M (2013-2017)
Table 61 Canada Hi Drugs Market, By Type, $M (2018-2023)
Table 62 Canada Hi Analogs Market, By Type, $M (2013-2017)
Table 63 Canada Hi Analogs Market, By Type, $M (2018-2023)
Table 64 Canada Hi Biologics Market, By Type, $M (2013-2017)
Table 65 Canada Hi Biologics Market, By Type, $M (2018-2023)
Table 66 Canada Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 67 Canada Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 68 Canada Hi Pens Market, By Type, $M (2013-2017)
Table 69 Canada Hi Pens Market, By Type, $M (2018-2023)
Table 70 Canada Hi Market, By Application, $M (2013-2017)
Table 71 Canada Hi Market, By Application, $M (2018-2023)
Table 72 Europe Hi Market, By Product, $M (2013-2017)
Table 73 Europe Hi Market, By Product, $M (2018-2023)
Table 74 Europe Hi Drugs Market, By Type, $M (2013-2017)
Table 75 Europe Hi Drugs Market, By Type, $M (2018-2023)
Table 76 Europe Hi Analogs Market, By Type, $M (2013-2017)
Table 77 Europe Hi Analogs Market, By Type, $M (2018-2023)
Table 78 Europe Hi Analogs Market, By Brand, $M (2013-2017)
Table 79 Europe Hi Analogs Market, By Brand, $M (2018-2023)
Table 80 Europe Hi Biologics Market, By Type, $M (2013-2017)
Table 81 Europe Hi Biologics Market, By Type, $M (2018-2023)
Table 82 Europe Hi Biologics Market, By Brand, $M (2013-2017)
Table 83 Europe Hi Biologics Market, By Brand, $M (2018-2023)
Table 84 Europe Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 85 Europe Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 86 Europe Hi Pens Market, By Type, $M (2013-2017)
Table 87 Europe Hi Pens Market, By Tyep, $M (2018-2023)
Table 88 Europe Hi Market, By Application, $M (2013-2017)
Table 89 Europe Hi Market, By Application, $M (2018-2023)
Table 90 Europe Hi Market, By Country, $M (2013-2017)
Table 91 Europe Hi Market, By Country, $M (2018-2023)
Table 92 Germany Hi Market, By Product, $M (2013-2017)
Table 93 Germany Hi Market, By Product, $M (2018-2023)
Table 94 Germany Hi Drugs Market, By Type, $M (2013-2017)
Table 95 Germany Hi Drugs Market, By Type, $M (2018-2023)
Table 96 Germany Hi Analogs Market, By Type, $M (2013-2017)
Table 97 Germany Hi Analogs Market, By Type, $M (2018-2023)
Table 98 Germany Hi Biologics Market, By Type, $M (2013-2017)
Table 99 Germany Hi Biologics Market, By Type, $M (2018-2023)
Table 100 Germany Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 101 Germany Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 102 Germany Hi Pens Market, By Type, $M (2013-2017)
Table 103 Germany Hi Pens Market, By Type, $M (2018-2023)
Table 104 Germany Hi Market, By Application, $M (2013-2017)
Table 105 Germany Hi Market, By Application, $M (2018-2023)
Table 106 France Hi Market, By Product, $M (2013-2017)
Table 107 France Hi Market, By Product, $M (2018-2023)
Table 108 France Hi Drugs Market, By Type, $M (2013-2017)
Table 109 France Hi Drugs Market, By Type, $M (2018-2023)
Table 110 France Hi Analogs Market, By Type, $M (2013-2017)
Table 111 France Hi Analogs Market, By Type, $M (2018-2023)
Table 112 France Hi Biologics Market, By Type, $M (2013-2017)
Table 113 France Hi Biologics Market, By Type, $M (2018-2023)
Table 114 France Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 115 France Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 116 France Hi Pens Market, By Type, $M (2013-2017)
Table 117 France Hi Pens Market, By Type, $M (2018-2023)
Table 118 France Hi Market, By Application, $M (2013-2017)
Table 119 France Hi Market, By Application, $M (2018-2023)
Table 120 U.K. Hi Market, By Product, $M (2013-2017)
Table 121 U.K. Hi Market, By Product, $M (2018-2023)
Table 122 U.K. Hi Drugs Market, By Type, $M (2013-2017)
Table 123 U.K. Hi Drugs Market, By Type, $M (2018-2023)
Table 124 U.K. Hi Analogs Market, By Type, $M (2013-2017)
Table 125 U.K. Hi Analogs Market, By Type, $M (2018-2023)
Table 126 U.K. Hi Biologics Market, By Type, $M (2013-2017)
Table 127 U.K. Hi Biologics Market, By Type, $M (2018-2023)
Table 128 U.K. Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 129 U.K. Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 130 U.K. Hi Pens Market, By Type, $M (2013-2017)
Table 131 U.K. Hi Pens Market, By Type, $M (2018-2023)
Table 132 U.K. Hi Market, By Application, $M (2013-2017)
Table 133 U.K. Hi Market, By Application, $M (2018-2023)
Table 134 Italy Hi Market, By Product, $M (2013-2017)
Table 135 Italy Hi Market, By Product, $M (2018-2023)
Table 136 Italy Hi Drugs Market, By Type, $M (2013-2017)
Table 137 Italy Hi Drugs Market, By Type, $M (2018-2023)
Table 138 Italy Hi Analogs Market, By Type, $M (2013-2017)
Table 139 Italy Hi Analogs Market, By Type, $M (2018-2023)
Table 140 Italy Hi Biologics Market, By Type, $M (2013-2017)
Table 141 Italy Hi Biologics Market, By Type, $M (2018-2023)
Table 142 Italy Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 143 Italy Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 144 Italy Hi Pens Market, By Type, $M (2013-2017)
Table 145 Italy Hi Pens Market, By Type, $M (2018-2023)
Table 146 Italy Hi Market, By Application, $M (2013-2017)
Table 147 Italy Hi Market, By Application, $M (2018-2023)
Table 148 Spain Hi Market, By Product, $M (2013-2017)
Table 149 Spain Hi Market, By Product, $M (2018-2023)
Table 150 Spain Hi Drugs Market, By Type, $M (2013-2017)
Table 151 Spain Hi Drugs Market, By Type, $M (2018-2023)
Table 152 Spain Hi Analogs Market, By Type, $M (2013-2017)
Table 153 Spain Hi Analogs Market, By Type, $M (2018-2023)
Table 154 Spain Hi Biologics Market, By Type, $M (2013-2017)
Table 155 Spain Hi Biologics Market, By Type, $M (2018-2023)
Table 156 Spain Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 157 Spain Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 158 Spain Hi Pens Market, By Type, $M (2013-2017)
Table 159 Spain Hi Pens Market, By Type, $M (2018-2023)
Table 160 Spain Hi Market, By Application, $M (2013-2017)
Table 161 Spain Hi Market, By Application, $M (2018-2023)
Table 162 APAC Hi Market, By Product, $M (2013-2017)
Table 163 APAC Hi Market, By Product, $M (2018-2023)
Table 164 APAC Hi Drugs Market, By Type, $M (2013-2017)
Table 165 APAC Hi Drugs Market, By Type, $M (2018-2023)
Table 166 APAC Hi Analogs Market, By Type, $M (2013-2017)
Table 167 APAC Hi Analogs Market, By Type, $M (2018-2023)
Table 168 APAC Hi Analogs Market, By Brand, $M (2013-2017)
Table 169 APAC Hi Analogs Market, By Brand, $M (2018-2023)
Table 170 APAC Hi Biologics Market, By Type, $M (2013-2017)
Table 171 APAC Hi Biologics Market, By Type, $M (2018-2023)
Table 172 APAC Hi Biologics Market, By Brand, $M (2013-2017)
Table 173 APAC Hi Biologics Market, By Brand, $M (2018-2023)
Table 174 APAC Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 175 APAC Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 176 APAC Hi Pens Market, By Type, $M (2013-2017)
Table 177 APAC Hi Pens Market, By Type, $M (2018-2023)
Table 178 APAC Hi Market, By Application, $M (2013-2017)
Table 179 APAC Hi Market, By Application, $M (2018-2023)
Table 180 APAC Hi Market, By Country, $M (2013-2017)
Table 181 APAC Hi Market, By Country, $M (2018-2023)
Table 182 Japan Hi Market, By Product, $M (2013-2017)
Table 183 Japan Hi Market, By Product, $M (2018-2023)
Table 184 Japan Hi Drugs Market, By Type, $M (2013-2017)
Table 185 Japan Hi Drugs Market, By Type, $M (2018-2023)
Table 186 Japan Hi Analogs Market, By Type, $M (2013-2017)
Table 187 Japan Hi Analogs Market, By Type, $M (2018-2023)
Table 188 Japan Hi Biologics Market, By Type, $M (2013-2017)
Table 189 Japan Hi Biologics Market, By Type, $M (2018-2023)
Table 190 Japan Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 191 Japan Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 192 Japan Hi Pens Market, By Type, $M (2013-2017)
Table 193 Japan Hi Pens Market, By Type, $M (2018-2023)
Table 194 Japan Hi Market, By Application, $M (2013-2017)
Table 195 Japan Hi Market, By Application, $M (2018-2023)
Table 196 China Hi Market, By Product, $M (2013-2017)
Table 197 China Hi Market, By Product, $M (2018-2023)
Table 198 China Hi Drugs Market, By Type, $M (2013-2017)
Table 199 China Hi Drugs Market, By Type, $M (2018-2023)
Table 200 China Hi Analogs Market, By Type, $M (2013-2017)
Table 201 China Hi Analogs Market, By Type, $M (2018-2023)
Table 202 China Hi Biologics Market, By Type, $M (2013-2017)
Table 203 China Hi Biologics Market, By Type, $M (2018-2023)
Table 204 China Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 205 China Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 206 China Hi Pens Market, By Type, $M (2013-2017)
Table 207 China Hi Pens Market, By Type, $M (2018-2023)
Table 208 China Hi Market, By Application, $M (2013-2017)
Table 209 China Hi Market, By Application, $M (2018-2023)
Table 210 India Hi Market, By Product, $M (2013-2017)
Table 211 India Hi Market, By Product, $M (2018-2023)
Table 212 India Hi Drugs Market, By Type, $M (2013-2017)
Table 213 India Hi Drugs Market, By Type, $M (2018-2023)
Table 214 India Hi Analogs Market, By Type, $M (2013-2017)
Table 215 India Hi Analogs Market, By Type, $M (2018-2023)
Table 216 India Hi Biologics Market, By Type, $M (2013-2017)
Table 217 India Hi Biologics Market, By Type, $M (2018-2023)
Table 218 India Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 219 India Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 220 India Hi Pens Market, By Type, $M (2013-2017)
Table 221 India Hi Pens Market, By Type, $M (2018-2023)
Table 222 India Hi Market, By Application, $M (2013-2017)
Table 223 India Hi Market, By Application, $M (2018-2023)
Table 224 Australia Hi Market, By Product, $M (2013-2017)
Table 225 Australia Hi Market, By Product, $M (2018-2023)
Table 226 Australia Hi Drugs Market, By Type, $M (2013-2017)
Table 227 Australia Hi Drugs Market, By Type, $M (2018-2023)
Table 228 Australia Hi Analogs Market, By Type, $M (2013-2017)
Table 229 Australia Hi Analogs Market, By Type, $M (2018-2023)
Table 230 Australia Hi Biologics Market, By Type, $M (2013-2017)
Table 231 Australia Hi Biologics Market, By Type, $M (2018-2023)
Table 232 Australia Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 233 Australia Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 234 Australia Hi Pens Market, By Type, $M (2013-2017)
Table 235 Australia Hi Pens Market, By Type, $M (2018-2023)
Table 236 Australia Hi Market, By Application, $M (2013-2017)
Table 237 Australia Hi Market, By Application, $M (2018-2023)
Table 238 LATAM Hi Market, By Product, $M (2013-2017)
Table 239 LATAM Hi Market, By Product, $M (2018-2023)
Table 240 LATAM Hi Drugs Market, By Type, $M (2013-2017)
Table 241 LATAM Hi Drugs Market, By Type, $M (2018-2023)
Table 242 LATAM Hi Analogs Market, By Type, $M (2013-2017)
Table 243 LATAM Hi Analogs Market, By Type, $M (2018-2023)
Table 244 LATAM Hi Analogs Market, By Brand, $M (2013-2017)
Table 245 LATAM Hi Analogs Market, By Brand, $M (2018-2023)
Table 246 LATAM Hi Biologics Market, By Type, $M (2013-2017)
Table 247 LATAM Hi Biologics Market, By Type, $M (2018-2023)
Table 248 LATAM Hi Biologics Market, By Brand, $M (2013-2017)
Table 249 LATAM Hi Biologics Market, By Brand, $M (2018-2023)
Table 250 LATAM Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 251 LATAM Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 252 LATAM Hi Pens Market, By Type, $M (2013-2017)
Table 253 LATAM Hi Pens Market, By Type, $M (2018-2023)
Table 254 LATAM Hi Market, By Application, $M (2013-2017)
Table 255 LATAM Hi Market, By Application, $M (2018-2023)
Table 256 LATAM Hi Market, By Country, $M (2013-2017)
Table 257 LATAM Hi Market, By Country, $M (2018-2023)
Table 258 Brazil Hi Market, By Product, $M (2013-2017)
Table 259 Brazil Hi Market, By Product, $M (2018-2023)
Table 260 Brazil Hi Drugs Market, By Type, $M (2013-2017)
Table 261 Brazil Hi Drugs Market, By Type, $M (2018-2023)
Table 262 Brazil Hi Analogs Market, By Type, $M (2013-2017)
Table 263 Brazil Hi Analogs Market, By Type, $M (2018-2023)
Table 264 Brazil Hi Biologics Market, By Type, $M (2013-2017)
Table 265 Brazil Hi Biologics Market, By Type, $M (2018-2023)
Table 266 Brazil Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 267 Brazil Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 268 Brazil Hi Pens Market, By Type, $M (2013-2017)
Table 269 Brazil Hi Pens Market, By Type, $M (2018-2023)
Table 270 Brazil Hi Market, By Application, $M (2013-2017)
Table 271 Brazil Hi Market, By Application, $M (2018-2023)
Table 272 Mexico Hi Market, By Product, $M (2013-2017)
Table 273 Mexico Hi Market, By Product, $M (2018-2023)
Table 274 Mexico Hi Drugs Market, By Type, $M (2013-2017)
Table 275 Mexico Hi Drugs Market, By Type, $M (2018-2023)
Table 276 Mexico Hi Analogs Market, By Type, $M (2013-2017)
Table 277 Mexico Hi Analogs Market, By Type, $M (2018-2023)
Table 278 Mexico Hi Biologics Market, By Type, $M (2013-2017)
Table 279 Mexico Hi Biologics Market, By Type, $M (2018-2023)
Table 280 Mexico Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 281 Mexico Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 282 Mexico Hi Pens Market, By Type, $M (2013-2017)
Table 283 Mexico Hi Pens Market, By Type, $M (2018-2023)
Table 284 Mexico Hi Market, By Application, $M (2013-2017)
Table 285 Mexico Hi Market, By Application, $M (2018-2023)
Table 286 MEA Hi Market, By Product, $M (2013-2017)
Table 287 MEA Hi Market, By Product, $M (2018-2023)
Table 288 MEA Hi Drugs Market, By Type, $M (2013-2017)
Table 289 MEA Hi Drugs Market, By Type, $M (2018-2023)
Table 290 MEA Hi Analogs Market, By Type, $M (2013-2017)
Table 291 MEA Hi Analogs Market, By Type, $M (2018-2023)
Table 292 MEA Hi Analogs Market, By Brand, $M (2013-2017)
Table 293 MEA Hi Analogs Market, By Brand, $M (2018-2023)
Table 294 MEA Hi Biologics Market, By Type, $M (2013-2017)
Table 295 MEA Hi Biologics Market, By Type, $M (2018-2023)
Table 296 MEA Hi Biologics Market, By Brand, $M (2013-2017)
Table 297 MEA Hi Biologics Market, By Brand, $M (2018-2023)
Table 298 MEA Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 299 MEA Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 300 MEA Hi Pens Market, By Type, $M (2013-2017)
Table 301 MEA Hi Pens Market, By Type, $M (2018-2023)
Table 302 MEA Hi Market, By Application, $M (2013-2017)
Table 303 MEA Hi Market, By Application, $M (2018-2023)
Table 304 MEA Hi Market, By Country, $M (2013-2017)
Table 305 MEA Hi Market, By Country, $M (2018-2023)
Table 306 Saudi Arabia Hi Market, By Product, $M (2013-2017)
Table 307 Saudi Arabia Hi Market, By Product, $M (2018-2023)
Table 308 Saudi Arabia Hi Drugs Market, By Type, $M (2013-2017)
Table 309 Saudi Arabia Hi Drugs Market, By Type, $M (2018-2023)
Table 310 Saudi Arabia Hi Analogs Market, By Type, $M (2013-2017)
Table 311 Saudi Arabia Hi Analogs Market, By Type, $M (2018-2023)
Table 312 Saudi Arabia Hi Biologics Market, By Type, $M (2013-2017)
Table 313 Saudi Arabia Hi Biologics Market, By Type, $M (2018-2023)
Table 314 Saudi Arabia Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 315 Saudi Arabia Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 316 Saudi Arabia Hi Pens Market, By Type, $M (2013-2017)
Table 317 Saudi Arabia Hi Pens Market, By Type, $M (2018-2023)
Table 318 Saudi Arabia Hi Market, By Application, $M (2013-2017)
Table 319 Saudi Arabia Hi Market, By Application, $M (2018-2023)
Table 320 South Africa Hi Market, By Product, $M (2013-2017)
Table 321 South Africa Hi Market, By Product, $M (2018-2023)
Table 322 South Africa Hi Drugs Market, By Type, $M (2013-2017)
Table 323 South Africa Hi Drugs Market, By Type, $M (2018-2023)
Table 324 South Africa Hi Analogs Market, By Type, $M (2013-2017)
Table 325 South Africa Hi Analogs Market, By Type, $M (2018-2023)
Table 326 South Africa Hi Biologics Market, By Type, $M (2013-2017)
Table 327 South Africa Hi Biologics Market, By Type, $M (2018-2023)
Table 328 South Africa Hi Delivery Devices Market, By Type, $M (2013-2017)
Table 329 South Africa Hi Delivery Devices Market, By Type, $M (2018-2023)
Table 330 South Africa Hi Pens Market, By Type, $M (2013-2017)
Table 331 South Africa Hi Pens Market, By Type Brand, $M (2018-2023)
Table 332 South Africa Hi Market, By Application, $M (2013-2017)
Table 333 South Africa Hi Market, By Application, $M (2018-2023)
Table 334 B. Braun Melsungen Ag - At A Glance
Table 335 B. Braun Melsungen Ag - Key Financial Summary
Table 336 Becton, Dickinson And Company - At A Glance
Table 337 Becton, Dickinson And Company - Key Financial Summary
Table 338 Eli Lilly And Company - At A Glance
Table 339 Eli Lilly And Company - Key Financial Summary
Table 340 Novo Nordisk A/S - At A Glance
Table 341 Novo Nordisk A/S - Key Financial Summary
Table 342 Sanofi - At A Glance
Table 343 Sanofi - Key Financial Summary
Table 344 Wockhardt Limited - At A Glance
Table 345 Wockhardt Limited - Key Financial Summary
Table 346 Ypsomed Holding Ag - At A Glance
Table 347 Ypsomed Holding Ag - Key Financial Summary
Table 348 Biocon Limited - At A Glance
Table 349 Biocon Limited - Key Financial Summary
Table 350 Medtronic Plc - At A Glance
Table 351 Medtronic Plc - Key Financial Summary
Table 352 Julphar - At A Glance
Table 353 Julphar - Key Financial Summary

List of Figures
Fig 1 Research Scope
Fig 2 Research Methodology
Fig 3 Regional Split Of Primary And Secondary Research
Fig 4 Breakdown Of Primary Research By Region
Fig 5 Breakdown Of Primary Research By Industry Participant
Fig 6 Breakdown Of Primary Research By Company Type
Fig 7 Data Triangulation Approach
Fig 8 Global Hi Market Summary
Fig 9 Number Of People Suffering From Diabetes Aged 20-79 Years, (2017 & 2045)
Fig 10 Bargaining Power Of Buyers
Fig 11 Bargaining Power Of Suppliers
Fig 12 Intensity Of Rivalry
Fig 13 Threat Of New Entrants
Fig 14 Threat Of Substitutes
Fig 15 Snapshot Of Hi Market (2017)
Fig 16 Global Hi Market, By Product, $M (2013-2023)
Fig 17 Global Hi Market, By Application, $M (2013-2023)
Fig 18 Worldwide Major Markets For Hi Drugs And Delivery Devices
Fig 19 North America Hi Market Snapshot
Fig 20 North America Hi Market, By Product, $M (2013-2023)
Fig 21 North America Hi Market, By Application, $M (2013-2023)
Fig 22 North America Hi Market, By Country, $M (2013-2023)
Fig 23 U.S. Hi Market, By Product, $M (2013-2023)
Fig 24 U.S. Hi Market, By Application, $M (2013-2023)
Fig 25 Canada Hi Market, By Product, $M (2013-2023)
Fig 26 Canada Hi Market, By Application, $M (2013-2023)
Fig 27 Europe Hi Market Snapshot
Fig 28 Europe Hi Market, By Product, $M (2013-2023)
Fig 29 Europe Hi Market, By Application, $M (2013-2023)
Fig 30 Europe Hi Market, By Country, $M (2013-2023)
Fig 31 Germany Hi Market, By Product, $M (2013-2023)
Fig 32 Germany Hi Market, By Application, $M (2013-2023)
Fig 33 France Hi Market, By Product, $M (2013-2023)
Fig 34 France Hi Market, By Application, $M (2013-2023)
Fig 35 U.K. Hi Market, By Product, $M (2013-2023)
Fig 36 U.K. Hi Market, By Application, $M (2013-2023)
Fig 37 Italy Hi Market, By Product, $M (2013-2023)
Fig 38 Italy Hi Market, By Application, $M (2013-2023)
Fig 39 Spain Hi Market, By Product, $M (2013-2023)
Fig 40 Spain Hi Market, By Application, $M (2013-2023)
Fig 41 APAC Hi Market Snapshot
Fig 42 APAC Hi Market, By Product, $M (2013-2023)
Fig 43 APAC Hi Market, By Application, $M (2013-2023)
Fig 44 APAC Hi Market, By Country, $M (2013-2023)
Fig 45 Japan Hi Market, By Product, $M (2013-2023)
Fig 46 Japan Hi Market, By Application, $M (2013-2023)
Fig 47 China Hi Market, By Product, $M (2013-2023)
Fig 48 China Hi Market, By Application, $M (2013-2023)
Fig 49 India Hi Market, By Product, $M (2013-2023)
Fig 50 India Hi Market, By Application, $M (2013-2023)
Fig 51 Australia Hi Market, By Product, $M (2013-2023)
Fig 52 Australia Hi Market, By Application, $M (2013-2023)
Fig 53 LATAM Hi Market Snapshot
Fig 54 LATAM Hi Market, By Product, $M (2013-2023)
Fig 55 LATAM Hi Market, By Application, $M (2013-2023)
Fig 56 LATAM Hi Market, By Country, $M (2013-2023)
Fig 57 Brazil Hi Market, By Product, $M (2013-2023)
Fig 58 Brazil Hi Market, By Application, $M (2013-2023)
Fig 59 Mexico Hi Market, By Product, $M (2013-2023)
Fig 60 Mexico Hi Market, By Application, $M (2013-2023)
Fig 61 MEA Hi Market Snapshot
Fig 62 MEA Hi Market, By Product, $M (2013-2023)
Fig 63 MEA Hi Market, By Application, $M (2013-2023)
Fig 64 MEA Hi Market, By Country, $M (2013-2023)
Fig 65 Saudi Arabia Hi Market, By Product, $M (2013-2023)
Fig 66 Saudi Arabia Hi Market, By Application, $M (2013-2023)
Fig 67 South Africa Hi Market, By Product, $M (2013-2023)
Fig 68 South Africa Hi Market, By Application, $M (2013-2023)
Fig 69 Global Hi Market Share Of Key Players (2017)
Fig 70 Product Benchmarking Of Key Players
Fig 71 B. Braun Melsungen Ag - Revenue Split By Division And Geography (2017)
Fig 72 Becton, Dickinson And Company - Revenue Split By Segment And Geography (2017)
Fig 73 Eli Lilly And Company - Revenue Split By Segment And Geography (2017)
Fig 74 Novo Nordisk A/S - Revenue Split By Segment And Geography (2017)
Fig 75 Sanofi - Revenue Split By Segment And Geography (2017)
Fig 76 Wockhardt Limited - Revenue Split By Geography (2018)
Fig 77 Ypsomed Holding Ag - Revenue Split By Segment And Geography (2018)
Fig 78 Biocon Limited - Revenue Split By Segment And Geography (2018)
Fig 79 Medtronic Plc - Revenue Split By Segment And Geography (2018)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Sanofi
  • Wockhardt Limited
  • Ypsomed Holding AG
  • Biocon Limited
  • Medtronic plc
  • Gulf Pharmaceutical Industries (Julphar)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4749615
Adroll
adroll